LTR Pharma (ASX:LTP) Shares Buyback Ratio %: -0.37 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:LTP LTR Pharma Ltd ASX:LTP
4 GF Score
Price A$0.46
View Full Analysis

What is LTR Pharma Shares Buyback Ratio %?

LTR Pharma ASX:LTP -6.19% 4 Shares Buyback Ratio % is -0.37 as of Aug. 06, 2026. GuruFocus rates ASX:LTP with a GF Score™ of 4/100.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. LTR Pharma's current shares buyback ratio was -0.37%.

LTR Pharma Shares Buyback Ratio % Related Terms

LTR Pharma Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Shares Buyback Ratio % Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Shares Buyback Ratio %
0.00 0.00 0.00 0.00 -29.81

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Buyback Ratio % Get a 7-Day Free Trial 0.00 0.00 -29.81 0.00 -0.37
ASX:LTP
4GF Score
LTR Pharma Ltd ASX:LTP
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Shares Buyback Ratio % Calculation

LTR Pharma's Shares Buyback Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Jun. 2025 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(139.420 - 180.978) / 139.420
=-29.81%

LTR Pharma's Shares Buyback Ratio for the quarter that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2025 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Jun. 2025 )
=(180.978 - 181.645) / 180.978
=-0.37%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -0.37 mean?
LTR Pharma (ASX:LTP) has a Shares Buyback Ratio % of -0.37 as of Aug. 06, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Shares Buyback Ratio % too high?
LTR Pharma's current Shares Buyback Ratio % is -0.37. Overall, LTR Pharma has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Shares Buyback Ratio % compare to VRTX and REGN?
LTR Pharma's Shares Buyback Ratio % of -0.37 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on LTR Pharma and its competitors. LTR Pharma's current Shares Buyback Ratio % is -0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Shares Buyback Ratio % of -0.37. The current Shares Buyback Ratio % is -0.37. LTR Pharma's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Shares Buyback Ratio % is -0.37 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
4GF Score

Get the complete analysis for ASX:LTP

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.46
Price